CIRT leads to temporary urinary function decline, normalizing within three months and stable for five years. Prostate volume decreases significantly without ADT, remaining reduced for five years. T ...

SAN FRANCISCO, September 29, 2025 — For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced patient-reported side effects compared to ...

Developing a manual clinical trials screening process in a diverse southern gynecologic oncology practice in the Deep South. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...

To report on the 15-year prostate cancer experience of our multidisciplinary genitourinary cancer clinic established in 1996 at the National Cancer Institute (NCI) –designated Jefferson Kimmel Cancer ...

Of all the health conditions facing men as they get older, there is no doubt that prostate cancer is the most widely ...

Four synthesized findings illustrate the nuanced experience of men undergoing ADT: symptom production, symptom perception, symptom meaning, and symptom response. Men undergoing androgen deprivation ...

Studies on whether pelvic lymph node dissection (PLND) provides a survival benefit in men with prostate cancer having surgery ...

A 68-year-old man presented to the emergency department with haematuria and penile pain. His medical history included benign prostatic hyperplasia, but no follow-up examinations had been performed.

As we gear up to observe World Cancer Day 2026 under the theme 'United by Unique', let's take a look at the stages of ...

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially ...

Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...

Prostate cancer is the most common solid malignancy among men in the United States. According to the American Cancer Society, an estimated 313,780 men nationwide will be diagnosed with the disease in ...